cCalculated with NIAD market volume (previously GLP-1) to prepare for RYBELSUS® access calculations. Sources: Data from Managed Markets Insight & Technology, LLC (MMIT) bridge. February 2022 Nomenclature, and IQVIA Xponent PlanTrak using week-ending 2/18/2022; only considers bridged volume; excludes cash and mail order data.
dNovo Nordisk defines formulary coverage as Preferred, Covered, or Covered with Restrictions. Coverage status and tier vary by plan and are subject to change. Please check directly with the health plan to confirm coverage for individual patients.
ePlan data based on number of pharmacy lives as reported by Managed Markets Insight & Technology, LLC (current as of February 2022). Applies to commercial business only. Formulary status is subject to change. Because formularies do change, and many health plans offer more than one formulary, please check directly with the health plan to confirm coverage for individual patients. 2022 Managed Markets Insight & Technology, LLC.
All rights reserved.